characteristics.text: SAMN37327545
characteristics.characteristic: External Id
characteristics.text: Molecular Genetics, The Weizmann Institute
characteristics.characteristic: INSDC center name
characteristics.text: 2024-02-18T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-02-18T07:46:07.584Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS18851720
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS18851720
characteristics.characteristic: SRA accession
characteristics.text: HEC-1A
characteristics.characteristic: cell line
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Endometrial Cancer, HEC-1A, CD133 sorted
characteristics.characteristic: source_name
characteristics.text: 1_shDAP5_CD133p
characteristics.characteristic: title
characteristics.text: HEC-1A endomertial cell line was KD with shRNA for EIF4G2 (DAP5) . The cells were subjected to sorting according to CD133 into CD133+ (p) and CD133- populations.
characteristics.characteristic: treatment